First-in-human phase I study of CetuGEX, a novel anti-EGFR monoclonal antibody (mAb) with optimized glycosylation and antibody dependent cellular cytotoxicity.
Walter Fiedler
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - Novartis; Pfizer
Cristiana Sessa
No relevant relationships to disclose
Luca Gianni
Consultant or Advisory Role - AstraZeneca; BioScience; Boehringer Ingelheim; Celgene; Genentech/Roche; GlaxoSmithKline; Novartis; Pfizer; Taiho Pharmaceutical
Sara Cresta
No relevant relationships to disclose
Henning Schulze-Bergkamen
No relevant relationships to disclose
Jens Weidmann
No relevant relationships to disclose
Sara De Dosso
No relevant relationships to disclose
Anna Tessari
No relevant relationships to disclose
Marc Oliver Salzberg
Consultant or Advisory Role - Glycotope GmbH
Hans Baumeister
Employment or Leadership Position - Glycotope GmbH
Stock Ownership - Glycotope GmbH
Antje Danielczyk
Employment or Leadership Position - Glycotope GmbH
Stock Ownership - Glycotope GmbH
Bruno Dietrich
Employment or Leadership Position - Glycotope GmbH
Johannes Nippgen
Employment or Leadership Position - Glycotope GmbH
Steffen Goletz
Employment or Leadership Position - Glycotope GmbH
Stock Ownership - Glycotope GmbH